- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- The effects of cyclosporin A, tamoxifen and medroxyprogesterone...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
The effects of cyclosporin A, tamoxifen and medroxyprogesterone acetate on the enhacement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells Claudio, Jerome Anthony A.
Abstract
Adriamycin (Adr), the single most active agent used in the treatment of breast cancer, may become ineffective as treatment progresses due to the development of multidrug resistant (MDR) tumors. A major mechanism associated with MDR is increased P-glycoprotein (Pgp) expression. This thesis examined the abilities of the antiestrogen tamoxifen (TAM) and the progestin medroxyprogesterone acetate (MPA) as well as cyclosporin A (CsA), a known resistance modifier, to enhance the cytotoxic effects of Adr on human breast epithelial cells (HBEC) in primary culture. Pgp and estrogen receptor (ER) expression were determined in each of the cultures by immunocytochemical assays using the monoclonal antibodies C219 and H222 Spy, respectively. The Adrsensitive, Pgp-, ER+ MCF-7 cell line and the Adr-resistant, Pgp+, ER- MCF7-AdrR cell line were used as controls. Primary cultures were categorized as HBEC from tissues with or without previous chemotherapy. Pgp was detected in 1 of the 15 cell cultures from tissues without previous chemotherapy and in 5 of the 6 cell cultures from tissues previously exposed to chemotherapy. Incubation with either CsA or MPA plus Adr enhanced Adr toxicity in Pgp+ but not Pgp- cell cultures, whereas T AM had no effect on the sensitivity of any of the cultures. Of the 21 primary cultures of HBEC, 3 were ER+. There was no correlation between the enhancement of Adr cytotoxicity and ER status. The data suggest that MPA as well as CsA may be useful as modifying agents in overcoming Pgp-associated multidrug resistance.
Item Metadata
Title |
The effects of cyclosporin A, tamoxifen and medroxyprogesterone acetate on the enhacement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
1995
|
Description |
Adriamycin (Adr), the single most active agent used in the treatment of breast
cancer, may become ineffective as treatment progresses due to the development of
multidrug resistant (MDR) tumors. A major mechanism associated with MDR is
increased P-glycoprotein (Pgp) expression. This thesis examined the abilities of the antiestrogen
tamoxifen (TAM) and the progestin medroxyprogesterone acetate (MPA) as well
as cyclosporin A (CsA), a known resistance modifier, to enhance the cytotoxic effects of
Adr on human breast epithelial cells (HBEC) in primary culture. Pgp and estrogen
receptor (ER) expression were determined in each of the cultures by immunocytochemical
assays using the monoclonal antibodies C219 and H222 Spy, respectively. The Adrsensitive,
Pgp-, ER+ MCF-7 cell line and the Adr-resistant, Pgp+, ER- MCF7-AdrR cell
line were used as controls. Primary cultures were categorized as HBEC from tissues with
or without previous chemotherapy. Pgp was detected in 1 of the 15 cell cultures from
tissues without previous chemotherapy and in 5 of the 6 cell cultures from tissues
previously exposed to chemotherapy. Incubation with either CsA or MPA plus Adr
enhanced Adr toxicity in Pgp+ but not Pgp- cell cultures, whereas T AM had no effect on
the sensitivity of any of the cultures. Of the 21 primary cultures of HBEC, 3 were ER+.
There was no correlation between the enhancement of Adr cytotoxicity and ER status.
The data suggest that MPA as well as CsA may be useful as modifying agents in
overcoming Pgp-associated multidrug resistance.
|
Extent |
8118653 bytes
|
Genre | |
Type | |
File Format |
application/pdf
|
Language |
eng
|
Date Available |
2009-01-31
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
|
DOI |
10.14288/1.0099024
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
1995-11
|
Campus | |
Scholarly Level |
Graduate
|
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.